您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（理学版）》

《山东大学学报(理学版)》 ›› 2023, Vol. 58 ›› Issue (7): 18-31.doi: 10.6040/j.issn.1671-9352.0.2021.417

•   • 上一篇    下一篇

竞争型医药供应链研发创新策略及行为选择

温艳*(),于溪源,胡劲松   

  1. 青岛大学商学院, 山东 青岛 266071
  • 收稿日期:2021-06-09 出版日期:2023-07-20 发布日期:2023-07-05
  • 通讯作者: 温艳 E-mail:wenyan@qdu.edu.cn
  • 作者简介:温艳(1979—), 女, 博士, 讲师, 研究方向为工业工程、医药供应链. E-mail: wenyan@qdu.edu.cn
  • 基金资助:
    国家自然科学基金资助项目(71771129);山东省自然科学基金资助项目(ZR2019MG001);青岛市博士后应用研究项目(40518060048)

R&D innovation strategy and behavior choice of competition drug supply chain

Yan WEN*(),Xiyuan YU,Jinsong HU   

  1. School of Business, Qingdao University, Qingdao 266071, Shandong, China
  • Received:2021-06-09 Online:2023-07-20 Published:2023-07-05
  • Contact: Yan WEN E-mail:wenyan@qdu.edu.cn

RichHTML

1

PDF (PC)

146

摘要：

针对竞争型医药供应链成员的短视与远见行为构建了4种动态微分博弈模型, 研究不同行为选择、竞争强度变动、医保报销比例对药品制造商研发创新投入、医疗机构成本分担策略及供应链绩效的影响。研究发现, 医药企业间的竞争性虽然损害了短视制造商的利润, 但增加了医药供应链整体绩效, 同时更有助于促进远见制造商更高的研发创新投入。伴随医保报销比例的提高, 远见药品制造商及医疗机构的利润均增加, 但无益于短视药品制造商。此外, 医疗机构为其中一制造商分担成本, 会抑制另一制造商利润的增长, 只有选择同时为两竞争制造商分担药品研发创新成本行为模式时, 才能对医药供应链各成员利润均有利。

关键词: 短视与远见, 成本分担, 微分博弈, 医药供应链, 竞争制造商

Abstract:

Based on the short-sighted and far-sighted behaviors of members of competitive drug supply chain, four dynamic differential game models were constructed to study the influences of different behavior choices, changes in competition intensity and reimbursement ratio of medical insurance on drug manufacturers' R & D innovation investment, medical institution' cost-sharing strategies and supply chain performance. The study found that although the competition between drug manufacturers harms the profits of short-sighted manufacturer, it increases the overall performance of the drug supply chain and promotes the higher R & D innovation investment of far-sighted manufacturer. With higher reimbursement rate, both far-sighted drug manufacturer and medical institution have increased their profits, but not short-sighted drug manufacturer. In addition, medical institution sharing costs with one manufacturer would depress the profits of the other, when medical institution choose the behavior mode of sharing drug R & D innovation costs for two competing manufacturers simultaneously, they can benefit the profits of all members of the drug supply chain.

Key words: short-sighted and far-sighted behaviors, cost sharing, differential game, drug supply chain, competing manufacturer

中图分类号: 

  • F224

图1

竞争型医药供应链模型架构"

表1

模型关键参数及其含义"

参数(i=1, 2) 含义
wi 制造商生产单位药品的边际利润
pi 医疗机构销售单位药品的边际价格
ρ 贴现因子
λ 研发创新投入对品牌商誉的影响因子
δ 制造商品牌商誉衰减系数
θ 扣除医保报销比例后的自付比例
m 医疗机构对制造商M1生产药品的推荐意愿
α、β、γ 边际价格、研发创新投入、品牌商誉分别对需求的影响因子
d 研发创新投入差异对需求的影响因子, 体现了制造商间的竞争强度
决策变量 Ii(t) t时刻的药品制造商研发创新投入
ϕ、Φ 医疗机构对制造商M1、M2的成本分担比例
状态变量 Gi(t) t时刻的制造商品牌商誉

表2

医保报销比例对供应链绩效的影响"

1-θ VSSM1 VM2SS VRSS VFSM1 VM2FS VRFS VSFM1 VSFM2 VRSF VFFM1 VFFM2 VRFF
↑ - ↑ ↑ - ↑ ↑ - ↑ ↑ - ↑ ↑
↓ - ↓ ↓ - ↓ ↓ - ↓ ↓ - ↓ ↓

图2

竞争强度对成员策略的影响"

图3

竞争强度对品牌商誉的影响"

图4

竞争强度对供应链利润的影响"

1 TANG X L , DU J . The performance of China's biomedical innovation: a scientometric analysis[J]. Science China Life Sciences, 2016, 59 (10): 1074- 1082.
doi: 10.1007/s11427-016-5078-6
2 YE X , WANG Q L , WANG H X . New era of drug innovation in China[J]. Acta Pharmaceutica Sinica B, 2019, 9 (5): 1084- 1085.
doi: 10.1016/j.apsb.2019.06.002
3 陈晓春, 张文松, 顾维军. 考虑技术研发和物流配送的医药供应链组合契约协调模型研究[J]. 中国管理科学, 2020, 28 (3): 80- 92.
doi: 10.16381/j.cnki.issn1003-207x.2020.03.009
CHEN Xiaochun , ZHANG Wensong , GU Weijun . Research on the coordination model of pharmaceutical supply chain considering technology R & D and logistics distribution full text replacement[J]. Chinese Journal of Management Science, 2020, 28 (3): 80- 92.
doi: 10.16381/j.cnki.issn1003-207x.2020.03.009
4 李亚林, 来小鹏. 美国药品专利保护期延长制度研究[J]. 中国新药杂志, 2020, 29 (4): 361- 366.
doi: 10.3969/j.issn.1003-3734.2020.04.001
LI Yalin , LAI Xiaopeng . Study on patent term extension of U.S.A[J]. Chinese Journal of New Drugs, 2020, 29 (4): 361- 366.
doi: 10.3969/j.issn.1003-3734.2020.04.001
5 THANIGAIMALAI Pillaiyar . A medicinal chemistry perspective of drug repositioning: recent advances and challenges in drug discovery[J]. European Journal of Medicinal Chemistry, 2020, 195, 112275.
doi: 10.1016/j.ejmech.2020.112275
6 陈志洪, 徐宏. 中国药品集中采购政策解读与实证分析[J]. 系统管理学报, 2021, 30 (1): 170- 179.
CHEN Zhihong , XU Hong . Theoretical interpretations and empirical analyses of China's drug volume-based procurement reform[J]. Journal of Systems & Management, 2021, 30 (1): 170- 179.
7 HASSAN Benchekroun . Could myopic pricing be a strategic choice in marketing channels? A game theoretic analysis[J]. Journal of Economic Dynamics and Control, 2009, 33 (9): 1699- 1718.
doi: 10.1016/j.jedc.2009.03.005
8 LU F X , LIU G W , ZHANG J X , et al. Benefits of partial myopia in a durable product supply chain considering pricing and advertising[J]. Journal of the Operational Research Society, 2016, 67 (10): 1309- 1324.
doi: 10.1057/jors.2016.27
9 WANG J , CHENG X X , WANG X Y , et al. Myopic versus farsighted behaviors in a low-carbon supply chain with reference emission effects[J]. Complexity, 2019, 2019, 1- 15.
10 LIU G W , SETHI S P , ZHANG J X . Myopic vs. far-sighted behaviours in a revenue-sharing supply chain with reference quality effects[J]. International Journal of Production Research, 2016, 54 (5): 1334- 1357.
doi: 10.1080/00207543.2015.1068962
11 LU F X , TANG W S , LIU G W , et al. Cooperative advertising: a way escaping from the prisoner's dilemma in a supply chain with sticky price[J]. Omega, 2019, 86, 87- 106.
doi: 10.1016/j.omega.2018.07.003
12 JOHARI M , HOSSEINI-MOTLAGH S M . Coordination contract for a competitive pharmaceutical supply chain considering corporate social responsibility and pricing decisions[J]. RAIRO-Operations Research, 2020, 54 (5): 1515- 1535.
doi: 10.1051/ro/2019073
13 Anshuman , Chutani . Dynamic cooperative advertising under manufacturer and retailer level competition[J]. European Journal of Operational Research, 2018, 268 (2): 635- 652.
doi: 10.1016/j.ejor.2018.02.027
14 杨艳, 程燕培, 陈收. 不同权力结构下供应链企业社会责任激励[J]. 中国管理科学, 2019, 27 (3): 144- 156.
doi: 10.16381/j.cnki.issn1003-207x.2019.03.015
YANG Yan , CHENG Yanpei , CHEN Shou . Stimulating corporate social responsibility in supply chain in different dominated modes[J]. Chinese Journal of Management Science, 2019, 27 (3): 144- 156.
doi: 10.16381/j.cnki.issn1003-207x.2019.03.015
15 胡劲松, 刘玉红, 马德青. 技术创新下考虑绿色度和溯源商誉的食品供应链动态策略[J]. 软科学, 2021, 35 (1): 39- 49.
doi: 10.3969/j.issn.1003-2800.2021.01.010
HU Jinsong , LIU Yuhong , MA Deqing . Dynamic strategy of food supply chain considering greenness and traceability goodwill under technological innovation[J]. Soft Science, 2021, 35 (1): 39- 49.
doi: 10.3969/j.issn.1003-2800.2021.01.010
16 曹裕, 胡韩莉, 李青松. 成本分担契约下绿色供应链的环境标签策略选择研究[J]. 中国管理科学, 2022, 30 (10): 119- 129.
CAO Yu , HU Hanli , LI Qingsong . Research on environmental labeling strategy selection of green supply chain under cost sharing contract[J]. Chinese Journal of Management Science, 2022, 30 (10): 119- 129.
17 孟庆春, 于宇, 金宗凯, 等. 考虑信息平台影响的供应链联合研发策略研究[J]. 山东大学学报(理学版), 2021, 56 (10): 149- 158.
MENG Qingchun , YU Yu , JIN Zongkai , et al. Research on supply chain joint R & D strategy considering the influence of information platform[J]. Journal of Shandong University(Natural Science), 2021, 56 (10): 149- 158.
18 李伟, 李凯. 考虑渠道势力和研发溢出的竞争制造商研发决策研究[J]. 中国管理科学, 2019, 27 (5): 196- 207.
doi: 10.16381/j.cnki.issn1003-207x.2019.05.020
LI Wei , LI Kai . The innovation decisions of competitive manufactures when considering channel power and spillover[J]. Chinese Journal of Management Science, 2019, 27 (5): 196- 207.
doi: 10.16381/j.cnki.issn1003-207x.2019.05.020
19 HUANG Zongsheng . Dynamic cooperative promotion models with competing retailers and negative promotional effects on brand image[J]. Computers & Industrial Engineering, 2018, 118, 291- 308.
20 许明辉, 刘晚霞. 制造商竞争环境下基于要素品牌战略的动态合作广告研究[J]. 管理工程学报, 2019, 33 (3): 162- 169.
doi: 10.13587/j.cnki.jieem.2019.03.019
XU Minghui , LIU Wanxia . Dynamic cooperative advertising with competitive manufacturers based on ingredient branding strategy[J]. Journal of Industrial Engineering and Engineering Management, 2019, 33 (3): 162- 169.
doi: 10.13587/j.cnki.jieem.2019.03.019
21 李凯, 李伟, 安岗. 链与链竞争背景下的制造商定价策略[J]. 系统管理学报, 2017, 26 (4): 771- 778.
LI Kai , LI Wei , AN Gang . Manufacturers' pricing decisions under the chain-to-chain competition[J]. Journal of Systems & Management, 2017, 26 (4): 771- 778.
22 纪雅杰, 马德青, 胡劲松. 消费者参考质量存在时滞效应的动态质量改进策略[J]. 山东大学学报(理学版), 2020, 55 (9): 89- 101.
JI Yajie , MA Deqing , HU Jinsong . Dynamic quality improvement strategies with delay effect in consumer reference quality[J]. Journal of Shandong University (Natural Science), 2020, 55 (9): 89- 101.
23 NERLOVE M , ARROW K J . Optimal advertising policy under dynamic conditions[J]. Economica, 1962, 29 (114): 129.
doi: 10.2307/2551549
24 杨丹丹, 侯文华. 考虑渠道竞争和医保政策的医药供应链双渠道定价策略[J]. 管理学报, 2019, 16 (6): 932- 938.
doi: 10.3969/j.issn.1672-884x.2019.06.016
YANG Dandan , HOU Wenhua . Pricing strategy of dual-channel pharmaceutical supply chain under channel competition and health insurance compensation[J]. Chinese Journal of Management, 2019, 16 (6): 932- 938.
doi: 10.3969/j.issn.1672-884x.2019.06.016
25 MARIA A , FRUTOS D . Competition in the pharmaceutical industry: how do quality differences shape advertising strategies?[J]. Journal of Health Economics, 2013, 32 (1): 268- 285.
doi: 10.1016/j.jhealeco.2012.07.006
26 荣俊美, 朱立龙. 政府管制下双渠道药品供应链质量控制策略[J]. 系统工程, 2019, 37 (5): 99- 108.
doi: 10.3969/j.issn.1001-2362.2019.05.073
RONG Junmei , ZHU Lilong . The quality control strategy of dual-channel drug supply chain under government regulation[J]. Systems Engineering, 2019, 37 (5): 99- 108.
doi: 10.3969/j.issn.1001-2362.2019.05.073
27 周艳菊, 叶欣, 詹结祥, 等. 制造商竞争与合作下双渠道供应链联合减排的微分博弈分析[J]. 控制与决策, 2018, 33 (11): 2021- 2028.
doi: 10.13195/j.kzyjc.2017.0818
ZHOU Yanju , YE Xin , ZHAN Jiexiang , et al. Differential game model of joint emission reduction strategies in a dual-channel supply chain considering manufacturers' competition and cooperation[J]. Control and Decision, 2018, 33 (11): 2021- 2028.
doi: 10.13195/j.kzyjc.2017.0818
28 李诗杨, 但斌, 李红霞. 公益性和自我药疗影响下的药品供应链定价与双渠道策略[J]. 管理学报, 2017, 14 (8): 1227- 1235.
doi: 10.3969/j.issn.1672-884x.2017.08.014
LI Shiyang , DAN Bin , LI Hongxia . Pricing and dual-channel strategies in pharmaceutical supply chain influence on public welfare and self-medication[J]. Chinese Journal of Management, 2017, 14 (8): 1227- 1235.
doi: 10.3969/j.issn.1672-884x.2017.08.014
[1] 姜吉坤,李宇,王威昊. 利他行为对动态供应链服务和定价决策的影响[J]. 《山东大学学报(理学版)》, 2022, 57(5): 97-110.
[2] 田双亮1,房保言1*, 王志刚2. 基于楔形基函数的微分博弈两点边值问题的逼近[J]. J4, 2011, 46(8): 38-41.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 唐风琴1,白建明2. 一类带有广义负上限相依索赔额的风险过程大偏差[J]. J4, 2013, 48(1): 100 -106 .
[2] 程智1,2,孙翠芳2,王宁1,杜先能1. 关于Zn的拉回及其性质[J]. J4, 2013, 48(2): 15 -19 .
[3] 汤晓宏1，胡文效2*，魏彦锋2，蒋锡龙2，张晶莹2，. 葡萄酒野生酿酒酵母的筛选及其生物特性的研究[J]. 山东大学学报（理学版）, 2014, 49(03): 12 -17 .
[4] 罗斯特,卢丽倩,崔若飞,周伟伟,李增勇*. Monte-Carlo仿真酒精特征波长光子在皮肤中的传输规律及光纤探头设计[J]. J4, 2013, 48(1): 46 -50 .
[5] 田学刚, 王少英. 算子方程AXB=C的解[J]. J4, 2010, 45(6): 74 -80 .
[6] 霍玉洪,季全宝. 一类生物细胞系统钙离子振荡行为的同步研究[J]. J4, 2010, 45(6): 105 -110 .
[7] 赵君1,赵晶2,樊廷俊1*,袁文鹏1,3,张铮1,丛日山1. 水溶性海星皂苷的分离纯化及其抗肿瘤活性研究[J]. J4, 2013, 48(1): 30 -35 .
[8] 杨永伟1,2,贺鹏飞2,李毅君2,3. BL-代数的严格滤子[J]. 山东大学学报（理学版）, 2014, 49(03): 63 -67 .
[9] 李敏1,2,李歧强1. 不确定奇异时滞系统的观测器型滑模控制器[J]. 山东大学学报（理学版）, 2014, 49(03): 37 -42 .
[10] 何海伦， 陈秀兰*. 变性剂和缓冲系统对适冷蛋白酶MCP-01和中温蛋白酶BP-01构象影响的圆二色光谱分析何海伦， 陈秀兰*[J]. 山东大学学报（理学版）, 2013, 48(1): 23 -29 .
版权所有 © 2018 《山东大学学报(理学版)》编辑部　
地址: 山东省济南市山大南路27号山东大学中心校区（250100）　电话: +86-0531-88366917　E-mail: xblxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发